Interventions description
DISEASE
A screening test had to be conducted for all patients who meet the inclusion criteria during the screening period in clinic. It included the general status of patients, symptoms, and signs associated with the disease, and laboratory detection, including the following: liver function, HOMA-IR, hemorrheologic, FibroTouch, and other examinations. The control group was treated by lifestyle modifications, including diet and exercise. Here, brisk walking was recommended to the patients in this group, and the exercise time had to be ≥150 min per week (